Literature DB >> 18496890

Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis.

M Sallée, E Crétel, R Jean, L Chiche, M Bourlière, P Poullin, P Lefèvre, J-M Durand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18496890     DOI： 10.1016/j.gcb.2007.12.019

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN： 0399-8320


× No keyword cloud information.
  4 in total

1.  Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.

Authors:  Corentin Orvain; Jean-François Augusto; Virginie Besson; Guillaume Marc; Paul Coppo; Jean-François Subra; Johnny Sayegh
Journal:  Int Urol Nephrol       Date:  2013-02-24       Impact factor: 2.370

Review 2.  Drug-induced glomerular disease: direct cellular injury.

Authors:  Glen S Markowitz; Andrew S Bomback; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-10       Impact factor: 8.237

3.  Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hepatol       Date:  2011-07-18

4.  Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab.

Authors:  Nishant Poddar; Jen C Wang
Journal:  Hematol Rep       Date:  2013-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.